Issue 5, 2025

Porphyrin-based porous organic polymer for the NIR-enhanced delivery of bupivacaine towards pain management in bacterial infection therapy

Abstract

Antibiotic-free strategies have gained widespread attention in combating bacterial infection-related wound therapy. Phototherapy is a precise treatment method that stands out from other therapeutic strategies. However, under the stimulus of local heat, patients might unconsciously touch the dressing at the infection sites, causing the dressing to fall off, thereby greatly diminishing the treatment effect. Therefore, pain management is quite essential in phototherapy. Herein, a porphyrin-based porous organic polymer (POP) with excellent photothermal capacities, denoted as P-POP, was developed as a carrier for the seamless integration of bupivacaine hydrochloride (BU), with both antibacterial and analgesic effects, to obtain a novel composite (P-POP-BU). The repetitive porphyrin units endowed excellent thermo-responsive properties to P-POP-BU, realizing the accelerated drug release following the local temperature increase triggered by laser illumination. P-POP-BU could realize the photo-enhanced BU release, enabling pain management during PTT. The antibacterial experiment demonstrated that the composite presented a synergistic and high-efficiency capacity to eradicate bacteria at the infection sites and significantly accelerate the repairing of wounds under laser irradiation. Notably, this special composite exhibited excellent biocompatibility with minimal side effects, making it a promising therapeutic platform for the light-triggered treatment of bacterial infections.

Graphical abstract: Porphyrin-based porous organic polymer for the NIR-enhanced delivery of bupivacaine towards pain management in bacterial infection therapy

Supplementary files

Article information

Article type
Paper
Submitted
06 Sep 2024
Accepted
23 Dec 2024
First published
03 Feb 2025
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2025,15, 3353-3364

Porphyrin-based porous organic polymer for the NIR-enhanced delivery of bupivacaine towards pain management in bacterial infection therapy

L. Chu, C. Dong, S. Wang, X. Ding, J. Yuan, P. Chen, Y. Luo and L. Yu, RSC Adv., 2025, 15, 3353 DOI: 10.1039/D4RA06433J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements